Navigation Links
St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer
Date:3/14/2008

Researchers discover that proteins BMP2, BMP4 and BMP7 inhibit the growth of medulloblastoma tumors, while inducing malignant cells to develop into normal neurons, a finding that may lead to better treatments for the cancer

MEMPHIS, Tenn., March 14 /PRNewswire-USNewswire/ -- A discovery by St. Jude Children's Research Hospital scientists suggests a safer way to treat medulloblastoma, a rare but often fatal childhood brain tumor. The group found that one of the brain's signaling pathways inhibits the growth of the highly aggressive cancer cells.

The researchers discovered that three proteins, designated BMP2, BMP4 and BMP7, halted the growth of medulloblastoma tumors and induced the malignant cells to develop into normal neurons.

"We think we have identified a pathway that can be used to prevent tumor formation and a potential target for therapy," said Martine F. Roussel, Ph.D., a member of the St. Jude Department of Genetics and Tumor Cell Biology. A report on this work appears in the March 15 issue of "Genes & Development." Roussel is the paper's senior author. Several research teams are seeking to decipher the intricate signaling mechanisms that govern the proliferation of cells called granule neuron progenitors (GNPs). These cells go on to develop into neurons in the cerebellum during the first year of life. But the disruption of this differentiation process can trigger medulloblastoma.

Previous research had shown that spurring GNPs to differentiate into neurons requires that BMPs bind to a set of receptors on the cell surface. This binding results in blocking the activity of a signaling pathway triggered by another molecule called Sonic hedgehog.

"What was not known, and what we now find, is that the effect of BMPs on normal GNP cells is almost exactly mimicked in GNP-like tumor cells," Roussel said.

In cell culture experiments, her group found that BMPs rapidly cause the degradation of a protein calle
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
2. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
3. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
4. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
5. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
6. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
8. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
9. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
10. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
11. Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...ICK, Md., Jan. 7 ImQuest Life Scie...an IND application to the Food and Drug Administra...ead pyrimidinedione HIV inhibitor IQP-0410. ImQues...the first quarter of 2009. IQP-0410 is a novel sma...as a nonnucleoside reverse transcriptase inhibitor...
(Date:1/6/2009)...m Expands on Successful Results from prior U.S., U...ewswire/ -- Vital Therapies, Inc. (VTI), a develop...announced patient enrollment has begun for a rando...trial that will study the Extracorporeal Liver Ass... Acute Liver Failure (ALF) under three protocols. ...
(Date:1/6/2009)...LLE, Md., Jan. 6 Sequel...ny focused on diseases of epidemic potential, anno...r the treatment of tuberculosis (TB), was the firs...clinical program contract to Dynport Vaccine Compa...awarded by the National Institute of Allergy and I...
(Date:1/5/2009)...EGO, Jan. 5 Cylene Pharmaceuticals...linical trial of its oral CK2 protein kinase inhib...ors, Castleman,s disease, or multiple myeloma. The...al are determination of safety, tolerance and PK p... dose for Phase II trials. In addition, multiple m...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3The sea ice is getting thinner 372 1The sea ice is getting thinner 372 2The sea ice is getting thinner 372 3The sea ice is getting thinner 372 4Nucletron Announces Management Buy Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community 1185 1Nucletron Announces Management Buy Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community 1185 2Nucletron Announces Management Buy Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community 1185 3MDMA Names New Director of Federal Affairs 1180 1MDMA Names New Director of Federal Affairs 1180 2Metabolic syndrome heightens risk for development of uric acid kidney stones 1179 1Metabolic syndrome heightens risk for development of uric acid kidney stones 1179 2
(Date:1/8/2009)..., NEW YORK, Jan. 8 New York City ...9 "IBREA Brain Education Day" and presented a proc...tional Brain Education Association) and developer ...itive training to enhance health, well-being, and ...ognized thought leader regarding the power of indi...
(Date:1/8/2009)..., ALEXANDRIA, Va., Jan. 8 /PRNewswire-USNewswire/...e Organization along with several national leaders...arding the principles of hospice care and protecti...ons standing together in sharing this unified mess...ation of Hospice and Palliative Medicine, Hospice ...
(Date:1/8/2009)... Molecules of sugar sitting on the surface of canc...ine aimed at both treating and stopping the spread...ich include prostate, breast, ovarian and lung, am...600,000 from the Gateway for Cancer Research, an I...st Alessandra Franco, M.D., Ph.D., and her co-work...
(Date:1/8/2009)..., New Allscripts Prenatal Solution Key Factor in ... CHICAGO and ORLANDO, Fla., Jan. 8 /PRNewswire-Fir...an Associates LLC, one of the largest multi-specia..., has selected the Allscripts Enterprise(TM) Elect...their 80 physicians in 18 offices across Central F...
Breaking Medicine News(10 mins):Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4
... implementing polio eradication strategies during ...ery and rehabilitation of polio victims. // "The ...pproved funds of Rs.10.39 billion for implementing...ear 2006-07," Information and Broadcasting Ministe...
...n the capital last year with, experts said Wednesd..., the same number of female foetuses were aborted ...ine expert, quoting records of the Delhi governmen...ltrasound clinics based on three months data, we f...
...ich held promise for being the best in the heap wi...he main objective of lowering the rate of the dise... The project has also overshot the budget and turn...not get the estimated participation, and was unabl...
...ditation and relaxation techniques, have proved be...hers at the University of Illinois says//. Adding...Martial arts such as Qigong and Taiji, practiced b...ial health benefits to older adults. Qigong (chee...
Other Medicine News:Health News:Older Adults could be Benefited from Chinese Martial-Arts 2Health News:Older Adults could be Benefited from Chinese Martial-Arts 3Health News:Older Adults could be Benefited from Chinese Martial-Arts 4
John weiss, wright acrylic globe.
Guthrie fixation hook, sharp double prongs.
Joseph Double Hook 10 mm wide. Designated most popular model or size.
Freer skin hook with blunt double prongs.
Medicine Products: